Citigroup’s Biofrontera BFRI Stock Holding History

Citigroup’s Portfolio BFRI Stock Details BFRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,837	Closed	-$9.58K	–	5742
2026 Q1	$9.58K	Buy	11,837 +11,836	+1,183,600%	+$10.2K	﹤0.01%	5058
2025 Q4	$1	Sell	1 -5,844	-100%	-$5.28K	﹤0.01%	5959
2025 Q3	$5.76K	Buy	+5,845	New	+$5.29K	﹤0.01%	5197
2022 Q3	–	Sell	-25	Closed	-$1K	–	5836
2022 Q2	$1K	Sell	25 -75	-75%	-$4.55K	﹤0.01%	5982
2022 Q1	$7K	Buy	+100	New	+$7.25K	﹤0.01%	5670

Other funds holding BFRI

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citigroup's BFRI Position: Q2 2026 in Review

Citigroup sold out of Biofrontera (BFRI) in Q2 2026, closing a stake of 11,837 shares — an estimated $9.58K sold.

Citigroup first reported a position in BFRI in Q1 2022 and held it in 5 quarters. The position peaked at $9.58K in Q1 2026. 19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

Citigroup reported no remaining Biofrontera position as of Q2 2026 after selling out during the quarter.
Citigroup sold 11,837 Biofrontera shares in Q2 2026, an estimated $9.58K.
Citigroup first reported a position in Biofrontera in Q1 2022 and held it in 5 quarters.
Citigroup's Biofrontera position peaked at $9.58K in Q1 2026.
19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.